[HTML] frontiersin.org

[HTML][HTML] Updated perspective of EPAS1 and the role in pulmonary hypertension

N Wang, J Hua, Y Fu, J An, X Chen, C Wang… - Frontiers in Cell and …, 2023 - frontiersin.org
Pulmonary hypertension (PH) is a group of syndromes characterized by irreversible vascular
remodeling and persistent elevation of pulmonary vascular resistance and pressure, leading …
被引用次数：10 相关文章
[HTML] nih.gov

[HTML][HTML] Updated perspective of EPAS1 and the role in pulmonary hypertension

N Wang, J Hua, Y Fu, J An, X Chen… - Frontiers in Cell and …, 2023 - ncbi.nlm.nih.gov
Pulmonary hypertension (PH) is a group of syndromes characterized by irreversible vascular
remodeling and persistent elevation of pulmonary vascular resistance and pressure, leading …

Updated perspective of EPAS1 and the role in pulmonary hypertension.

N Wang, J Hua, Y Fu, J An, X Chen… - Frontiers in Cell and …, 2023 - europepmc.org
Pulmonary hypertension (PH) is a group of syndromes characterized by irreversible vascular
remodeling and persistent elevation of pulmonary vascular resistance and pressure, leading …

Updated perspective of EPAS1 and the role in pulmonary hypertension

N Wang, J Hua, Y Fu, J An, X Chen… - Frontiers in cell …, 2023 - pubmed.ncbi.nlm.nih.gov
Pulmonary hypertension (PH) is a group of syndromes characterized by irreversible vascular
remodeling and persistent elevation of pulmonary vascular resistance and pressure, leading …

Updated perspective of EPAS1 and the role in pulmonary hypertension.

N Wang, J Hua, Y Fu, J An, X Chen… - Frontiers in Cell and …, 2023 - europepmc.org
Pulmonary hypertension (PH) is a group of syndromes characterized by irreversible vascular
remodeling and persistent elevation of pulmonary vascular resistance and pressure, leading …